IPOTracker
eToroTrade IPO stocks the day they listStart on eToro
All companies
IA

Iambic Therapeutics Inc

IAM
Public
PublicUnited StatesUSUnited States(NASDAQ Global Select)Best valuation $1.13BSince IPO +48.81%1 market

Public listing

Listed· NASDAQ Global Select· Listing market: United StatesUS United States
Listing date
Oct 15, 2026
Final IPO price
$16.00
Shares offered
9,375,000
Offering proceeds
$150M

Sources: sec-edgar, sec-harvest, nasdaq

IPO Calendar
IPO Calendar · NASDAQIPO
IAM
Price
$23.81
24h
+25.91%
Valuation
$1.13B
24h volume
$70.59M
Type
IPO
IPO CalendarTrade Iambic Therapeutics Inc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 36m ago

Iambic Therapeutics Inc IPO unlock schedule & public float

Lock-up schedule, public float and locked shares extracted from Iambic Therapeutics Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4Oct 15, 2026
Total shares (FD)
47.4M
Public float
9.38M
Locked
38.03M
IPO raise
$150M
Next unlock
Apr 13, 2027 · 38.03M
Shares eligible to trade · by holder groupOct 15, 2026 → Apr 13, 2027 · 100% unlocked
  • Lock-up holders38.03M
  • IPO public float9.38M

SEC IPO filings

Final prospectus

EDGAR filings resolved from IAM / CIK 0001997038.

424B4424B4
Oct 15, 2026Final prospectus0001193125-26-422865
8-A12B8-A12B
Oct 13, 2026Exchange registration0001193125-26-420387
S-1/AS-1/A
Oct 8, 2026Amended0001193125-26-417416
S-1S-1
Sep 21, 2026Filed0001193125-26-396704
DRS/Afilename1.htm
Aug 28, 2026Confidential draft0001193125-26-374173
DRSfilename1.htm
Jul 24, 2026Confidential draft0001193125-26-315779

Iambic Therapeutics Inc IPO — frequently asked questions

When did Iambic Therapeutics Inc go public?
Iambic Therapeutics Inc completed its IPO on Oct 15, 2026 on NASDAQ Global Select under the ticker IAM and now trades publicly.
What was Iambic Therapeutics Inc's IPO price?
Iambic Therapeutics Inc priced its IPO at $16.00 per share.
Can I buy Iambic Therapeutics Inc stock?
Yes — Iambic Therapeutics Inc is publicly traded on NASDAQ Global Select as IAM. You can follow its live price, valuation and post-IPO performance above.
What is Iambic Therapeutics Inc's valuation?
Iambic Therapeutics Inc's most recent valuation tracked here is $1.13B, derived from live market prices.